Haleon's First-Quarter Results Align With Peers -- Market Talk
Dow Jones04-29
0746 GMT - Haleon's first-quarter results are consistent with those of peers like Reckitt, as a less severe cold and flu season affected performance, analysts at RBC Capital Markets write in a note. Meanwhile, growth is expected to accelerate over the remainder of the year, and North America had better-than-expected performance amid a declining market, the analysts add. A pain relief miss shows that Advil sales declined with weakness in the U.S., they add. Shares are down 2.4% at 342.30 pence. (aimee.look@wsj.com)
(END) Dow Jones Newswires
April 29, 2026 03:46 ET (07:46 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments